News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
481,649 Results
Type
Article (18423)
Company Profile (81)
Press Release (463140)
Multimedia
Podcasts (68)
Webinars (8)
Section
Business (140248)
Career Advice (724)
Deals (26096)
Drug Delivery (96)
Drug Development (56039)
Employer Resources (78)
FDA (13524)
Job Trends (9975)
News (241748)
Policy (23379)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (899)
Accelerated approval (21)
Adcomms (16)
Allergies (112)
Alliances (36527)
ALS (95)
Alzheimer's disease (949)
Antibody-drug conjugate (ADC) (173)
Approvals (13836)
Artificial intelligence (292)
Autoimmune disease (101)
Automation (29)
Bankruptcy (210)
Best Places to Work (8079)
BIOSECURE Act (13)
Biosimilars (177)
Biotechnology (51)
Bladder cancer (98)
Brain cancer (30)
Breast cancer (312)
Cancer (2831)
Cardiovascular disease (240)
Career advice (626)
Career pathing (9)
CAR-T (210)
CDC (23)
Cell therapy (588)
Cervical cancer (25)
Clinical research (49087)
Collaboration (1173)
Company closure (1)
Compensation (473)
Complete response letters (37)
COVID-19 (1538)
CRISPR (52)
C-suite (497)
Cystic fibrosis (85)
Data (4229)
Denatured (16)
Depression (91)
Diabetes (378)
Diagnostics (4463)
Digital health (27)
Diversity (3)
Diversity, equity & inclusion (8)
Drug discovery (137)
Drug pricing (131)
Drug shortages (28)
Duchenne muscular dystrophy (170)
Earnings (63201)
Editorial (25)
Employer branding (8)
Employer resources (64)
Events (69328)
Executive appointments (653)
FDA (16046)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (770)
Gene editing (122)
Generative AI (22)
Gene therapy (446)
GLP-1 (646)
Government (2942)
Grass and pollen (7)
Guidances (352)
Healthcare (10683)
HIV (35)
Huntington's disease (29)
IgA nephropathy (69)
Immunology and inflammation (139)
Immuno-oncology (29)
Indications (82)
Infectious disease (1711)
Inflammatory bowel disease (113)
Inflation Reduction Act (11)
Influenza (84)
Intellectual property (187)
Interviews (99)
IPO (11887)
IRA (34)
Job creations (2212)
Job search strategy (547)
JPM (38)
Kidney cancer (12)
Labor market (33)
Layoffs (306)
Leadership (9)
Legal (4679)
Liver cancer (54)
Longevity (8)
Lung cancer (413)
Lymphoma (255)
Machine learning (20)
Management (39)
Manufacturing (757)
MASH (103)
Medical device (10893)
Medtech (10936)
Mergers & acquisitions (15045)
Metabolic disorders (879)
Multiple sclerosis (112)
NASH (8)
Neurodegenerative disease (169)
Neuropsychiatric disorders (45)
Neuroscience (1699)
Neurotech (1)
NextGen: Class of 2026 (3584)
Non-profit (1199)
Now hiring (22)
Obesity (393)
Opinion (155)
Ovarian cancer (86)
Pain (124)
Pancreatic cancer (144)
Parkinson's disease (169)
Partnered (20)
Patents (363)
Patient recruitment (290)
Peanut (44)
People (38326)
Pharmaceutical (32)
Pharmacy benefit managers (15)
Phase 1 (14780)
Phase 2 (21379)
Phase 3 (17038)
Pipeline (4115)
Policy (178)
Postmarket research (1550)
Preclinical (5688)
Press Release (67)
Prostate cancer (149)
Psychedelics (22)
Radiopharmaceuticals (197)
Rare diseases (529)
Real estate (3952)
Recruiting (30)
Regulatory (19134)
Reports (27)
Research institute (921)
Resumes & cover letters (87)
Rett syndrome (20)
RNA editing (10)
RSV (50)
Schizophrenia (95)
Series A (109)
Series B (87)
Service/supplier (7)
Sickle cell disease (58)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (25)
Startups (2282)
State (1)
Stomach cancer (2)
Supply chain (102)
Tariffs (75)
The Weekly (52)
Vaccines (603)
Venture capital (35)
Weight loss (268)
Women's health (54)
Worklife (11)
Date
Last 7 days (390)
Last 30 days (1348)
Last 365 days (20187)
2026 (1837)
2025 (20578)
2024 (24699)
2023 (28821)
2022 (38471)
2021 (41283)
2020 (39336)
2019 (30890)
2018 (23550)
2017 (24366)
2016 (22275)
2015 (26561)
2014 (19120)
2013 (15768)
2012 (17534)
2011 (18246)
2010 (16020)
Location
Africa (406)
Alabama (57)
Alaska (2)
Arizona (134)
Arkansas (9)
Asia (31295)
Australia (5054)
California (7215)
Canada (2232)
China (860)
Colorado (298)
Connecticut (322)
Delaware (207)
Europe (64837)
Florida (1174)
Georgia (285)
Hawaii (3)
Idaho (40)
Illinois (631)
India (54)
Indiana (408)
Iowa (8)
Japan (325)
Kansas (104)
Kentucky (12)
Louisiana (13)
Maine (76)
Maryland (967)
Massachusetts (5094)
Michigan (290)
Minnesota (365)
Mississippi (4)
Missouri (105)
Montana (21)
Nebraska (14)
Nevada (94)
New Hampshire (60)
New Jersey (2384)
New Mexico (24)
New York (2048)
North Carolina (973)
North Dakota (7)
Northern California (3477)
Ohio (230)
Oklahoma (12)
Oregon (27)
Pennsylvania (1557)
Puerto Rico (19)
Rhode Island (29)
South America (747)
South Carolina (58)
South Dakota (1)
Southern California (2878)
Tennessee (118)
Texas (1079)
United States (26764)
Utah (186)
Vermont (1)
Virginia (208)
Washington D.C. (39)
Washington State (581)
West Virginia (4)
Wisconsin (69)
Wyoming (2)
481,649 Results for "artms products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
Telix Pharmaceuticals Limited announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc., its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure rare metals required for consumable target production.
March 4, 2024
·
11 min read
Deals
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
April 11, 2024
·
3 min read
Press Releases
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B customers to address the forecasted increased demand for products
December 17, 2025
·
5 min read
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channel
January 23, 2026
·
6 min read
Press Releases
TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States
Access to an audience of over 19 million individuals monthly will expand national exposure, and supports scalable demand generation across B2C and B2B channels for TempraMed’s full product portfolio
February 2, 2026
·
6 min read
Press Releases
USP launches resources to support product quality for GLP-1 agonists
Dedicated solutions for these complex products can help enable confidence in the accuracy of analytical results
October 23, 2025
·
1 min read
Press Releases
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
January 12, 2026
·
6 min read
Press Releases
Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products
January 27, 2026
·
2 min read
Press Releases
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
February 2, 2026
·
3 min read
ARTMS Inc. Announces Health Canada Submission for Ga-68 Production and Tri-party Collaboration to Advance Ga-68 Imaging Products
ARTMS Inc. (ARTMS), the global leader in developing and commercializing novel products enabling cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce the submission of a Type 1 Master File with the Health Products & Food Branch, Health Canada (HC) for the production of gallium-68 (Ga-68).
October 14, 2021
·
5 min read
1 of 48,165
Next
